Form 4: HCSG EVP & Chief Revenue Officer Exercises, Sells 45,500 Shares
Insider Transaction Report
Healthcare Services Group's EVP & Chief Revenue Officer, Patrick J. Orr, exercised stock options and sold an equal number of common shares for personal liquidity.
Summary
- Patrick J. Orr, EVP & Chief Revenue Officer of HEALTHCARE SERVICES GROUP INC (HCSG), engaged in transactions on February 18, 2026.
- Mr. Orr exercised stock options to acquire a total of 45,500 shares of common stock.
- The exercise prices for these options ranged from $10.36 to $18.1 per share.
- Simultaneously, Mr. Orr sold 45,500 shares of common stock at a price of $20.54 per share.
- Following these transactions, Mr. Orr's direct beneficial ownership of common stock is 44,615 shares.
- Mr. Orr also retains derivative securities (stock options) for an aggregate of 54,886 shares, with various exercise prices and expiration dates.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event. It represents a routine executive compensation transaction (exercise and sell) rather than a strong signal of confidence or concern about the company's future performance.
Positives
- The exercise of stock options indicates that the underlying stock price was above the exercise price, allowing the executive to realize a profit.
- The sale price of $20.54 per share is higher than all the exercise prices, confirming a profitable transaction for the insider.
Negatives
- The sale of 45,500 shares by a key executive could be interpreted as a reduction in direct equity exposure to the company, although it is a common practice for option exercises.
Future Outlook
NA
Industry Context
StockSavvy.ai notes that executive option exercises and subsequent sales are a routine part of compensation structures in the healthcare services industry, allowing executives to monetize vested equity while managing personal finances. This transaction aligns with typical insider activity seen across publicly traded companies.
Comparison to Industry Standards
- The exercise-and-sell strategy is a standard practice for executives across various sectors, including healthcare, to manage equity compensation and tax obligations. For example, similar transactions are frequently observed at companies like Aramark (ARMK) or Sodexo (SW.PA), which also operate in facility management and food services, where executives monetize vested stock awards.
- The volume of shares sold (45,500) represents a significant transaction for an individual executive but is not uncommon for a Chief Revenue Officer at a company of HCSG's size, especially when compared to similar-level executives at peers like Compass Group (CPG.L) or ABM Industries (ABM).
Related Party Transactions
- Patrick J. Orr, an EVP & Chief Revenue Officer, engaged in the exercise of stock options and subsequent sale of common stock, which are transactions between an insider and the company's securities market.
Stakeholder Impact
- Shareholders: The sale of shares by an executive could be perceived as a slight reduction in direct insider exposure, but it is often understood as a routine part of personal financial planning and tax management, not necessarily a lack of confidence in the company's long-term prospects.
- Employees: No direct impact on employees is indicated by this filing.
- Customers/Suppliers/Creditors: No direct impact on these stakeholders is indicated by this filing.
Key Dates
| Date | Description |
|---|---|
| 01/04/2022 | Grant date for stock options with an exercise price of $18.1, vesting annually at 20%. |
| 02/24/2023 | Grant date for stock options with an exercise price of $13.72, vesting annually at 20%. |
| 01/03/2024 | Grant date for stock options with an exercise price of $10.36, vesting annually at 20%. |
| 01/03/2025 | Grant date for stock options with an exercise price of $11.76, vesting annually at 20%. |
| 02/18/2026 | Date of stock option exercises and subsequent sale of common stock. |
| 02/19/2026 | Date of signature for the filing by Michael Harrity, by Power of Attorney. |
| 01/04/2032 | Expiration date for stock options with an exercise price of $18.1. |
| 02/24/2033 | Expiration date for stock options with an exercise price of $13.72. |
| 01/03/2034 | Expiration date for stock options with an exercise price of $10.36. |
| 01/03/2035 | Expiration date for stock options with an exercise price of $11.76. |
Recommendation
holdThe filing details a routine insider transaction where an executive exercised stock options and sold an equivalent number of shares. This 'exercise and sell' strategy is common for liquidity and tax planning and does not inherently signal a change in the company's fundamental outlook or the executive's long-term confidence. Therefore, it does not warrant a change in investment recommendation based solely on this filing.
Keywords
Healthcare Services Group, HCSG, Insider Trading, Stock Options, Executive Compensation, SEC Form 4, Patrick J. Orr, Share Sale, Option Exercise
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.